The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study
2001
Objectives: To assess the effect and tolerance of a 6–week course of intravesical valrubicin on a tumour intentionally left in the bladder (marker lesion) following incomplete trans
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
42
Citations
NaN
KQI